Articles from LaserAway

LaserAway Expands Medical Aesthetics Portfolio with Launch of Salmon DNA Facial, XTherma and Wellness Injections
LaserAway, the nation’s leading provider of aesthetic dermatology, recently announced the launch of three new services across its clinics: Salmon DNA Facial, XTherma and an expanded portfolio of LaserAway Wellness Injections. The additions reflect continued investment in science-backed treatments and the brand’s medical-first approach to growth.
By LaserAway · Via Business Wire · March 3, 2026
LaserAway Announces Strategic Investment by Ares Management
LaserAway, a leading provider of aesthetic dermatology, announced today a strategic investment made by funds managed by the Private Equity Group of Ares Management Corporation (NYSE: ARES) (“Ares”). Terms of the investment were not disclosed.
By LaserAway · Via Business Wire · October 21, 2021